Rejoinder to commentary by Drs. Boaz Musafia and Gilad Rosenberg von Pan, Pei-Yin, Cortese, Samuele, Bölte, Sven

Volltext

Attention-deficit/hyperactivity disorder, headache and caffeine von Musafia, Boaz, Rosenberg, Gilad

Volltext

Results of Membrane-activated Chelator Stroke Intervention Randomized Trial of DP-b99 in Acute Ischemic Stroke von LEES, Kennedy R, BORNSTEIN, Natan, DIENER, Hans-Christoph, GORELICK, Philip B, ROSENBERG, Gilad, SHUAIB, Ashfaq

Volltext

Reader response: Upgoing thumb sign: A sensitive indicator of brain involvement? von Rosenberg, Gilad

Volltext

Letter re: Calcium supplementation and risk of dementia in women with cerebrovascular disease von Rosenberg, Gilad

Volltext

Tandem Breastfeeding and Human Milk Macronutrients: A Prospective Observational Study von Rosenberg, Gilad, Mangel, Laurence, Mandel, Dror, Marom, Ronella, Lubetzky, Ronit

Volltext

And why not thrombolysis in the ambulance (at least for some)? von Rosenberg, Gilad, Steiner, Israel

Volltext

Reversion from mild cognitive impairment to normal or near-normal cognition: Risk factors and prognosis von Rosenberg, Gilad

Volltext

The effect of shocks to GDP on employment in SADC member states during COVID‐19 using a Bayesian hierarchical model von Strauss, Ilan, Isaacs, Gilad, Rosenberg, Josh

Volltext

The impact of R353Q genetic polymorphism in coagulation factor VII on the initial anticoagulant effect exerted by warfarin von Shaul, Chanan, Blotnick, Simcha, Deutsch, Liat, Rosenberg, Gilad, Caraco, Yoseph

Volltext

Methylphenidate therapy, headaches and caffeine consumption von Musafia, Boaz, Rosenberg, Gilad

Volltext

Methylphenidate Therapy, Headaches and Caffeine Consumption von Musafia, Boaz, Rosenberg, Gilad

Volltext

The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal Phase II... von Rosenberg, Gilad, Bornstein, Natan, Diener, Hans-Christoph, Gorelick, Philip B., Shuaib, Ashfaq, Lees, Kennedy

Volltext

RECANALIZATION AFTER INTRAVENOUS THROMBOLYSIS: DOES A RECANALIZATION TIME WINDOW EXIST? von Gotkine, Marc, Rosenberg, Gilad, Steiner, Israel

Volltext

The Neuroprotective Agent DP‐b99 Does Not Interact with S‐warfarin In Vivo Despite Significant CYP2C9 Inhibition In Vitro von Rosenberg, Gilad, Marshall, Linda S., Caraco, Yoseph

Volltext

The Neuroprotective Agent DPab99 Does Not Interact with Sawarfarin In Vivo Despite Significant CYP2C9 Inhibition In Vitro von Rosenberg, Gilad, Marshall, Linda S, Caraco, Yoseph

Volltext

Clinical pharmacology of DP‐b99 in healthy volunteers: First administration to humans von Rosenberg, Gilad, Angel, Itzchak, Kozak, Alex

Volltext

DP-b99, a Membrane-Activated Metal Ion Chelator, as Neuroprotective Therapy in Ischemic Stroke von DIENER, Hans-Christoph, SCHNEIDER, Dietmar, LAMPL, Yair, BORNSTEIN, Natan M, KOZAK, Alexander, ROSENBERG, Gilad

Volltext

Evidence for Positive Selection and Population Structure at the Human MAO-A Gene von Gilad, Yoav, Rosenberg, Shai, Przeworski, Molly, Lancet, Doron, Skorecki, Karl

Volltext

Metal ion chelation in neurodegenerative disorders von Angel, Itzchak, Bar, Adina, Horovitz, Tammy, Taler, Galia, Krakovsky, Michael, Resnitsky, Dalia, Rosenberg, Gilad, Striem, Sarina, Friedman, Jonathan E., Kozak, Alex

Volltext